CASP6 and Huntington disease: Transgenic mice expressing mHtt that is resistant to caspase-6 cleavage at AA 586 do not develop the HD-like symptoms seen in their caspase-6-sensitive counterparts, despite the presence of other caspase cleavage products in the brain [9].